igf 1 lr3 clinical trial human GMP IGF-I/IGF-1 Protein, (83a.a, E51R) QK041 - Recombinant human/bovine/porcine IGF-1
Description
The drawback with PDT is that its incredibly painful
Contraindication of therapy includes hypersensitivity to the drug and severe liver or kidney disease
doi: 10.1093/brain/awu231
Whether these Ca 2+ alterations in neurofibromin haploinsufficient cells install adaptations that are relevant also in NF1-related tumors is an intriguing possibility
